Skip to main content

and
  1. Article

    Open Access

    FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML

    Yannan Jia, Weiguo Zhang, Mahesh Basyal, Kyung Hee Chang, Lauren Ostermann in Leukemia (2023)

  2. Article

    Open Access

    Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy

    Barbara Muz, Feda Azab, Mark Fiala, Justin King, Daniel Kohnen in Blood Cancer Journal (2019)

  3. Article

    Open Access

    Disease modifying and antiangiogenic activity of 2-Methoxyestradiol in a murine model of rheumatoid arthritis

    A critical component of disease progression in rheumatoid arthritis (RA) involves neovascularization associated with pannus formation. 2-methoxyestradiol (2ME2) is a naturally occurring molecule with no known ...

    Stacy M Plum, Eun J Park, Steve J Strawn in BMC Musculoskeletal Disorders (2009)

  4. Article

    Open Access

    ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo

    Hepatocellular carcinoma (HCC) represents a highly vascularized tumor entity and the process of angiogenesis is essential for the growth of HCC. Importantly, the pro-angiogenic transcription factors HIF-1α and...

    Christian Moser, Sven A Lang, Akira Mori, Claus Hellerbrand, Hans J Schlitt in BMC Cancer (2008)

  5. No Access

    Article

    Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells

    Using a nonviral, electroporation-based gene transfection approach, we demonstrate the efficient and consistent transfection of two poorly immunogenic tumor cell lines: B16F10 melanoma and renal carcinoma (REN...

    Jonathan M Weiss, Rama Shivakumar, Stephanie Feller, Lin-Hong Li in Cancer Gene Therapy (2004)

  6. No Access

    Article

    Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile

    Endostatin, a potent endogenous inhibitor of angiogenesis, inhibits the growth of primary tumors without induction of acquired drug resistance in mice. We report that a soluble recombinant human (rh) Endostati...

    B. Kim Lee Sim, William E. Fogler, **n Hua Zhou, Hong Liang, John W. Madsen in Angiogenesis (1999)

  7. No Access

    Article

    Biological characterization of a chimeric mouse-human IgM antibody directed against the 17-1A antigen

    A chimeric antibody was constructed in which the murine H- and L-chain variable regions of mAb 17-1A, raised against human colorectal cancer cells, were joined with the human constant μ and κ regions. Transfec...

    William E. Fogler, Lee K. Sun, Mark R. Klinger in Cancer Immunology, Immunotherapy (1989)

  8. No Access

    Article

    Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon

    Human recombinant gamma interferon (INF-γ) activated human peripheral blood monocytes to a cytotoxic state capable of lysing adherent tumorigenic cells without harming normal cells. The efficiency of INF-γ act...

    Wayne C. Koff, William E. Fogler, Jordan Gutterman in Cancer Immunology, Immunotherapy (1985)

  9. No Access

    Article

    Toxicity studies of liposome-encapsulated immunomodulators administered intravenously to dogs and mice

    Multilamellar liposomes containing lymphokines from mitogen-stimulated rat lymphocytes were injected IV into BALB/c or (C57BL/6×C3H)F1 mice and Beagle dogs to evaluate their potential toxicity. Animals receive...

    Ian R. Hart, William E. Fogler, George Poste in Cancer Immunology, Immunotherapy (1981)